Given that ERβ1 is expressed in both ERα-positive and ERα-negative breast tumors, we sought to compare a number of different therapeutic strategies to determine which might be most effective for the treatment of patients with ERβ1-positive breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.